ZYXI vs. CUTR, BLFS, AXGN, SMLR, OM, EDAP, ELMD, FONR, HYPR, and VANI
Should you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Cutera (CUTR), BioLife Solutions (BLFS), AxoGen (AXGN), Semler Scientific (SMLR), Outset Medical (OM), Edap Tms (EDAP), Electromed (ELMD), FONAR (FONR), Hyperfine (HYPR), and Vivani Medical (VANI). These companies are all part of the "electromedical equipment" industry.
Zynex (NASDAQ:ZYXI) and Cutera (NASDAQ:CUTR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.
Zynex has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Cutera has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.
Cutera received 310 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 64.80% of users gave Cutera an outperform vote while only 54.35% of users gave Zynex an outperform vote.
Zynex has a net margin of 4.33% compared to Cutera's net margin of -73.42%. Zynex's return on equity of 16.34% beat Cutera's return on equity.
Zynex has higher earnings, but lower revenue than Cutera. Cutera is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
In the previous week, Zynex had 15 more articles in the media than Cutera. MarketBeat recorded 18 mentions for Zynex and 3 mentions for Cutera. Cutera's average media sentiment score of 0.96 beat Zynex's score of -0.36 indicating that Cutera is being referred to more favorably in the news media.
29.7% of Zynex shares are owned by institutional investors. Comparatively, 90.7% of Cutera shares are owned by institutional investors. 52.1% of Zynex shares are owned by insiders. Comparatively, 0.4% of Cutera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Zynex presently has a consensus target price of $14.00, suggesting a potential upside of 56.77%. Cutera has a consensus target price of $7.67, suggesting a potential upside of 404.39%. Given Cutera's higher probable upside, analysts clearly believe Cutera is more favorable than Zynex.
Summary
Zynex beats Cutera on 10 of the 17 factors compared between the two stocks.
Get Zynex News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
